Evidence map›Paper›PMID 29724817›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2018

Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.

Fang Wang, Zun Liu, Se-Hyung Park, Taesik Gwag, Weiwei Lu, Murong Ma, Yipeng Sui, Changcheng Zhou

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 45 citations in OpenAlex.

  1. Myeloid Cell-Specific Deletion of LGR4 Suppresses Atherosclerotic Lesion Formation.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  2. Cellular signaling meets bacterial infection: the integrative role of STAT3.Frontiers in cellular and infection microbiology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fang WangFrom the Department of Pharmacology and Nutritional Sciences (F.W., Z.L., S.-H.P., T.G., W.L., M.M., Y.S., C.Z.).
Zun LiuFrom the Department of Pharmacology and Nutritional Sciences (F.W., Z.L., S.-H.P., T.G., W.L., M.M., Y.S., C.Z.).
Se-Hyung ParkFrom the Department of Pharmacology and Nutritional Sciences (F.W., Z.L., S.-H.P., T.G., W.L., M.M., Y.S., C.Z.).
Taesik GwagFrom the Department of Pharmacology and Nutritional Sciences (F.W., Z.L., S.-H.P., T.G., W.L., M.M., Y.S., C.Z.).
Weiwei LuFrom the Department of Pharmacology and Nutritional Sciences (F.W., Z.L., S.-H.P., T.G., W.L., M.M., Y.S., C.Z.).
Murong MaFrom the Department of Pharmacology and Nutritional Sciences (F.W., Z.L., S.-H.P., T.G., W.L., M.M., Y.S., C.Z.).
Yipeng SuiFrom the Department of Pharmacology and Nutritional Sciences (F.W., Z.L., S.-H.P., T.G., W.L., M.M., Y.S., C.Z.).
Changcheng ZhouFrom the Department of Pharmacology and Nutritional Sciences (F.W., Z.L., S.-H.P., T.G., W.L., M.M., Y.S., C.Z.) c.zhou@uky.edu.
University of Kentucky · US

Funding

The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2012 to 2017
$13.7M
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosisR01ES023470 · NIEHS · UNIVERSITY OF KENTUCKY · PI ZHOU, CHANGCHENG · 2013 to 2022
$2.7M
Role of IKKβ in obesity and atherosclerosisR01HL131925 · NHLBI · UNIVERSITY OF KENTUCKY · PI ZHOU, CHANGCHENG · 2016 to 2019
$1.5M
A novel mechanism for ART-associated dyslipidemia and atherosclerosisR01HL123358 · NHLBI · UNIVERSITY OF KENTUCKY · PI ZHOU, CHANGCHENG · 2015 to 2018
$1.5M
Mechanisms of atherogenic effects of bisphenol AR21ES022745 · NIEHS · UNIVERSITY OF KENTUCKY · PI ZHOU, CHANGCHENG · 2014 to 2015
$413k
NHLBI NIH HHS R01 HL123358NHLBI NIH HHS R01 HL131925NIEHS NIH HHS R01 ES023470NIEHS NIH HHS R21 ES022745NIGMS NIH HHS P20 GM103527
6 · The paper itself

Abstract

objectiveThe Wnt/β-catenin signaling is an ancient and evolutionarily conserved pathway that regulates essential aspects of cell differentiation, proliferation, migration and polarity. Canonical Wnt/β-catenin signaling has also been implicated in the pathogenesis of atherosclerosis. Macrophage is one of the major cell types involved in the initiation and progression of atherosclerosis, but the role of macrophage β-catenin in atherosclerosis remains elusive. This study aims to investigate the impact of β-catenin expression on macrophage functions and atherosclerosis development. APPROACH AND

resultsTo investigate the role of macrophage canonical Wnt/β-catenin signaling in atherogenesis, we generated β-catenin

conclusionsThis study demonstrates a critical role of myeloid β-catenin expression in atherosclerosis by modulating macrophage inflammatory responses.

Indexed as

Plaque, AtheroscleroticAnimalsAortaAortic DiseasesAtherosclerosisbeta CateninCell AdhesionCell MovementDiet, High-FatDisease Models, AnimalDisease ProgressionLipidsMacrophagesMaleMiceMice, Knockoutbeta CateninCTNNB1 protein, mouseLipidsReceptors, LDLStat1 protein, mouseSTAT1 Transcription FactorStat3 protein, mouseSTAT3 Transcription Factoratherosclerosisinflammationlow-density lipoprotein receptormacrophageβ-catenin

Identifiers

PMID29724817
PMCPMC6023740
OpenAlexW2803089807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.